Development
Molina Healthcare, Inc.
MOH
$296.88
$3.321.13%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.19% | 7.30% | 8.21% | 11.80% | 15.33% |
| Total Other Revenue | -27.54% | -10.14% | -15.28% | -21.05% | -9.21% |
| Total Revenue | 6.12% | 7.26% | 8.15% | 11.72% | 15.26% |
| Cost of Revenue | 5.50% | 6.26% | 6.98% | 10.85% | 14.64% |
| Gross Profit | 10.39% | 14.32% | 16.63% | 17.99% | 19.70% |
| SG&A Expenses | 6.36% | 8.18% | 7.39% | 7.62% | 11.75% |
| Depreciation & Amortization | -2.84% | 6.71% | 17.88% | 30.43% | 34.35% |
| Other Operating Expenses | 61.11% | 90.57% | 53.85% | 50.00% | 35.00% |
| Total Operating Expenses | 5.62% | 6.57% | 7.13% | 10.74% | 14.54% |
| Operating Income | 16.82% | 22.97% | 32.93% | 36.18% | 33.05% |
| Income Before Tax | 37.72% | 11.78% | 22.19% | 25.38% | 21.49% |
| Income Tax Expenses | 37.64% | 14.18% | 23.32% | 29.33% | 25.46% |
| Earnings from Continuing Operations | 37.75% | 10.97% | 21.81% | 24.09% | 20.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.75% | 10.97% | 21.81% | 24.09% | 20.18% |
| EBIT | 16.82% | 22.97% | 32.93% | 36.18% | 33.05% |
| EBITDA | 14.61% | 21.12% | 31.21% | 35.53% | 33.19% |
| EPS Basic | 37.96% | 11.38% | 22.53% | 24.76% | 20.24% |
| Normalized Basic EPS | 18.69% | 25.85% | 37.63% | 42.02% | 38.38% |
| EPS Diluted | 38.49% | 11.82% | 22.76% | 24.79% | 20.29% |
| Normalized Diluted EPS | 19.20% | 26.48% | 38.08% | 42.27% | 38.65% |
| Average Basic Shares Outstanding | -0.26% | -0.30% | -0.47% | -0.39% | -0.04% |
| Average Diluted Shares Outstanding | -0.68% | -0.73% | -0.73% | -0.51% | -0.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |